These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8594663)

  • 1. [T cell activation].
    Takase K; Saito T
    Ryumachi; 1995 Oct; 35(5):853-61. PubMed ID: 8594663
    [No Abstract]   [Full Text] [Related]  

  • 2. CD4 enhances T cell sensitivity to antigen by coordinating Lck accumulation at the immunological synapse.
    Li QJ; Dinner AR; Qi S; Irvine DJ; Huppa JB; Davis MM; Chakraborty AK
    Nat Immunol; 2004 Aug; 5(8):791-9. PubMed ID: 15247914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [T cell membrane raft domains: its function in T cell activation].
    Saitoh S; Nagafuku M; Kosugi A
    Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2234-41. PubMed ID: 12518442
    [No Abstract]   [Full Text] [Related]  

  • 5. The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate.
    Yasutomo K; Doyle C; Miele L; Fuchs C; Germain RN
    Nature; 2000 Mar; 404(6777):506-10. PubMed ID: 10761920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
    Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling costimulation.
    van der Merwe PA
    Nat Immunol; 2000 Sep; 1(3):194-5. PubMed ID: 10973274
    [No Abstract]   [Full Text] [Related]  

  • 8. T cell costimulation through the CD28 receptor.
    Green JM; Noel PJ; Sperling AI; Walunas TL; Lenschow DJ; Stack R; Gray GS; Bluestone JA; Thompson CB
    Proc Assoc Am Physicians; 1995 Apr; 107(1):41-6. PubMed ID: 8630743
    [No Abstract]   [Full Text] [Related]  

  • 9. CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response.
    Radvanyi LG; Shi Y; Vaziri H; Sharma A; Dhala R; Mills GB; Miller RG
    J Immunol; 1996 Mar; 156(5):1788-98. PubMed ID: 8596028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.
    Chen L
    Nat Rev Immunol; 2004 May; 4(5):336-47. PubMed ID: 15122199
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
    Fenton RG; Turcovski-Corrales SM; Taub DD
    J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purified MHC class I and peptide complexes activate naive CD8+ T cells independently of the CD28/B7 and LFA-1/ICAM-1 costimulatory interactions.
    Goldstein JS; Chen T; Brunswick M; Mostowsky H; Kozlowski S
    J Immunol; 1998 Apr; 160(7):3180-7. PubMed ID: 9531273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Why T cells?].
    Koyasu S
    Tanpakushitsu Kakusan Koso; 2000 Aug; 45(11):1795-800. PubMed ID: 10936963
    [No Abstract]   [Full Text] [Related]  

  • 14. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of T cell adhesion by antigen stimulation and modulation by the coreceptor CD4.
    Michel F; Acuto O
    Cell Immunol; 1996 Nov; 173(2):165-75. PubMed ID: 8912873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell alloreactivity to major histocompatibility complex peptides in context of self major histocompatibility complex.
    Suciu-Foca N; Xi YP; Sun YK; Liu Z
    Transplant Proc; 1993 Feb; 25(1 Pt 1):73-4. PubMed ID: 8438461
    [No Abstract]   [Full Text] [Related]  

  • 17. Different activation signals detected by fixation of stimulator cells.
    Sutherland RM; Boyle W
    Transplant Proc; 1989 Feb; 21(1 Pt 1):178-9. PubMed ID: 2784892
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathways of human T lymphocyte development and activation.
    Alcover A; Milanese C; Reinherz EL
    Bioessays; 1986 Jun; 4(6):259-64. PubMed ID: 3491607
    [No Abstract]   [Full Text] [Related]  

  • 19. Do CD4 or CD8 molecules provide a regulatory signal in T-cell activation?
    Fleischer B; Schrezenmeier H
    Immunol Today; 1988 May; 9(5):132-4. PubMed ID: 3151439
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of cell-to-cell interactions in T lymphocyte development and activation.
    Littman DR
    Curr Opin Cell Biol; 1989 Oct; 1(5):920-8. PubMed ID: 2697295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.